$EXAS
EXACT SCIENCES CORP Stock $exas

$exas Overview Financials Valuation SEC Filings Company Website

2012 Q1 Form 10-K Financial Statement

#000104746912002372 Filed on March 09, 2012

Income Statement

Concept	2012 Q1	2010 Q4	2010
Revenue	$1.036M	$1.400M	$5.344M
YoY Change	-0.38%	16.67%	12.32%
Cost Of Revenue	$0.00	$0.00	$24.00K
YoY Change	-100.0%		20.0%
Gross Profit	$1.036M	$1.400M	$5.320M
YoY Change	0.19%	16.67%	12.28%
Gross Profit Margin	100.0%	100.0%	99.55%
Selling, General & Admin	$2.739M	$2.700M	$8.123M
YoY Change	11.93%	50.0%	-16.9%
% of Gross Profit	264.38%	192.86%	152.69%
Research & Development	$8.999M	$2.500M	$9.023M
YoY Change	201.07%	92.31%	114.17%
% of Gross Profit	868.63%	178.57%	169.61%
Depreciation & Amortization	$202.0K	$0.00	$230.0K
YoY Change	201.49%	-100.0%	187.5%
% of Gross Profit	19.5%	0.0%	4.32%
Operating Expenses	$11.74M	$5.200M	$17.15M
YoY Change	115.93%	67.74%	22.6%
Operating Profit	-$10.70M	-$3.800M	-$11.83M
YoY Change	143.12%	100.0%	27.89%
Interest Expense	$5.000K	$0.00	$20.00K
YoY Change	0.0%		-80.0%
% of Operating Profit
Other Income/Expense, Net		$200.0K	$200.0K
YoY Change
Pretax Income	-$10.60M	-$3.600M	-$11.60M
YoY Change	140.91%	89.47%	27.47%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$10.60M	-$3.600M	-$11.60M
YoY Change	140.91%	89.47%	27.47%
Net Earnings / Revenue	-1023.17%	-257.14%	-217.07%
Basic Earnings Per Share
Diluted Earnings Per Share	-$186.9K	-$76.60K	-$286.4K
COMMON SHARES
Basic Shares Outstanding	57.02M shares		40.46M shares
Diluted Shares Outstanding			40.46M shares

Balance Sheet

Concept	2012 Q1	2010 Q4	2010
SHORT-TERM ASSETS
Cash & Short-Term Investments	$83.50M	$95.40M	$95.40M
YoY Change	-6.91%	292.59%	292.59%
Cash & Equivalents	$12.29M	$78.75M	$78.80M
Short-Term Investments	$71.20M	$16.70M	$16.70M
Other Short-Term Assets	$1.900M	$200.0K	$200.0K
YoY Change	280.0%	-80.0%	-80.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$85.45M	$95.66M	$95.70M
YoY Change	-5.26%	278.11%	278.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.551M	$854.0K	$900.0K
YoY Change	155.1%	70.8%	80.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$2.551M	$854.0K	$800.0K
YoY Change	155.1%	70.8%	60.0%
TOTAL ASSETS
Total Short-Term Assets	$85.45M	$95.66M	$95.70M
Total Long-Term Assets	$2.551M	$854.0K	$800.0K
Total Assets	$88.01M	$96.52M	$96.50M
YoY Change	-3.5%	274.09%	274.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$900.0K	$1.028M	$1.000M
YoY Change	12.5%	414.0%	400.0%
Accrued Expenses	$2.600M	$1.987M	$2.000M
YoY Change	85.71%	41.93%	42.86%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.692M	$7.158M	$7.200M
YoY Change	20.19%	10.12%	10.77%
LONG-TERM LIABILITIES
Long-Term Debt	$1.000M	$1.000M	$1.000M
YoY Change	0.0%	0.0%	0.0%
Other Long-Term Liabilities	$3.500M	$8.600M	$8.600M
YoY Change	-53.95%	-29.51%	-29.51%
Total Long-Term Liabilities	$4.500M	$1.000M	$9.600M
YoY Change	-47.67%	-92.42%	-27.27%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.692M	$7.158M	$7.200M
Total Long-Term Liabilities	$4.500M	$1.000M	$9.600M
Total Liabilities	$12.10M	$8.158M	$16.80M
YoY Change	-19.33%	-58.59%	-14.72%
SHAREHOLDERS EQUITY
Retained Earnings		-$193.1M
YoY Change
Common Stock		$272.9M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$75.86M	$79.75M	$79.80M
YoY Change
Total Liabilities & Shareholders Equity	$88.01M	$96.52M	$96.50M
YoY Change	-3.5%	274.09%	274.03%

Cashflow Statement

Concept	2012 Q1	2010 Q4	2010
OPERATING ACTIVITIES
Net Income	-$10.60M	-$3.600M	-$11.60M
YoY Change	140.91%	89.47%	27.47%
Depreciation, Depletion And Amortization	$202.0K	$0.00	$230.0K
YoY Change	201.49%	-100.0%	187.5%
Cash From Operating Activities	-$11.20M	-$4.100M	-$13.40M
YoY Change	103.64%	28.13%	6.35%
INVESTING ACTIVITIES
Capital Expenditures	$195.0K	-$100.0K	$626.0K
YoY Change	-20.41%	-75.0%	35.5%
Acquisitions
YoY Change
Other Investing Activities	-$13.70M	-$2.700M	-$14.30M
YoY Change	1270.0%	-250.0%	495.83%
Cash From Investing Activities	-$13.90M	-$2.800M	-$14.90M
YoY Change	1058.33%	-315.38%	413.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$64.70M	$82.33M
YoY Change			921.17%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.600M	64.90M	85.20M
YoY Change		6390.0%	162.15%
NET CHANGE
Cash From Operating Activities	-11.20M	-4.100M	-13.40M
Cash From Investing Activities	-13.90M	-2.800M	-14.90M
Cash From Financing Activities	1.600M	64.90M	85.20M
Net Change In Cash	-23.50M	58.00M	56.90M
YoY Change	250.75%	-6544.44%	234.71%
FREE CASH FLOW
Cash From Operating Activities	-$11.20M	-$4.100M	-$13.40M
Capital Expenditures	$195.0K	-$100.0K	$626.0K
Free Cash Flow	-$11.40M	-$4.000M	-$14.03M
YoY Change	98.35%	42.86%	7.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2010Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52163629	shares
CY2010Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52163629	shares
CY2010Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2010Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2010Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2010Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2010Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2010Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2010Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2010Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1000	USD
CY2010Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	272380000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	96953000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	83495000	USD
CY2010Q4	us-gaap	Common Stock Value CommonStockValue	522000	USD
CY2011Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2010Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	96515000	USD
CY2010Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56624763	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56624763	shares
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	79754000	USD
CY2010Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-193149000	USD
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2011Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2011Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2011Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2010Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	8582000	USD
CY2010Q4	exas	Interest Payable Noncurrent InterestPayableNoncurrent	21000	USD
CY2010Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2010Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7158000	USD
CY2010Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4143000	USD
CY2010Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1987000	USD
CY2010Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1028000	USD
CY2010Q4	us-gaap	Assets Assets	96515000	USD
CY2010Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	854000	USD
CY2010Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	386000	USD
CY2010Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1240000	USD
CY2010Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	20000	USD
CY2010Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	89000	USD
CY2010Q4	exas	Office And Computer Equipment Gross OfficeAndComputerEquipmentGross	188000	USD
CY2010Q4	exas	Laboratory Equipment Gross LaboratoryEquipmentGross	943000	USD
CY2010Q4	us-gaap	Assets Current AssetsCurrent	95661000	USD
CY2010Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	246000	USD
CY2010Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	16663000	USD
CY2010	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	15460	shares
CY2009	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	50000	USD
CY2009	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	100000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78752000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7977000	USD
CY2011Q4	us-gaap	Assets Assets	96953000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2558000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3354000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	94395000	USD
CY2010	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40455000	shares
CY2010	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40455000	shares
CY2010	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.29
CY2010	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11556000	USD
CY2010	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	244000	USD
CY2010	us-gaap	Investment Income Interest InvestmentIncomeInterest	46000	USD
CY2010	us-gaap	Operating Income Loss OperatingIncomeLoss	-11826000	USD
CY2010	us-gaap	Operating Expenses OperatingExpenses	17146000	USD
CY2010	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1793000	USD
CY2010	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6330000	USD
CY2010	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9023000	USD
CY2010	us-gaap	Gross Profit GrossProfit	5320000	USD
CY2010	us-gaap	Cost Of Revenue CostOfRevenue	24000	USD
CY2010	us-gaap	Revenues Revenues	5344000	USD
CY2010	us-gaap	Licenses Revenue LicensesRevenue	5318000	USD
CY2010	us-gaap	Royalty Revenue RoyaltyRevenue	26000	USD
CY2009	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32791000	shares
CY2009	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32791000	shares
CY2009	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.28
CY2009	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9128000	USD
CY2009	us-gaap	Investment Income Interest InvestmentIncomeInterest	120000	USD
CY2009	us-gaap	Operating Income Loss OperatingIncomeLoss	-9247000	USD
CY2009	us-gaap	Operating Expenses OperatingExpenses	13985000	USD
CY2009	us-gaap	Restructuring Charges RestructuringCharges	-3000	USD
CY2009	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	226000	USD
CY2009	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9549000	USD
CY2009	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4213000	USD
CY2009	us-gaap	Gross Profit GrossProfit	4738000	USD
CY2009	us-gaap	Cost Of Revenue CostOfRevenue	20000	USD
CY2009	us-gaap	Revenues Revenues	4758000	USD
CY2009	us-gaap	Licenses Revenue LicensesRevenue	4733000	USD
CY2009	us-gaap	Royalty Revenue RoyaltyRevenue	25000	USD
CY2011	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28675000	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-28823000	USD
CY2011	us-gaap	Operating Expenses OperatingExpenses	32962000	USD
CY2011	us-gaap	Gross Profit GrossProfit	4139000	USD
CY2011	us-gaap	Revenues Revenues	4163000	USD
CY2011	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	27872	shares
CY2009	us-gaap	Deferred Compensation Arrangement With Individual Employer Contribution DeferredCompensationArrangementWithIndividualEmployerContribution	32000	USD
CY2009	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss	1000	USD
CY2009Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21924000	USD
CY2008Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4937000	USD
CY2009	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	32494000	USD
CY2009	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	732000	USD
CY2009	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8062000	USD
CY2009	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	6000000	USD
CY2009	us-gaap	Proceeds From Collaborators ProceedsFromCollaborators	16650000	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	27900000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-43047000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-27824000	USD
CY2009	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2867000	USD
CY2009	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	462000	USD
CY2009	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	16474000	USD
CY2009	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	18879000	USD
CY2009	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-12640000	USD
CY2009	us-gaap	Increase Decrease In Royalties Payable IncreaseDecreaseInRoyaltiesPayable	-2462000	USD
CY2009	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1000	USD
CY2009	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-81000	USD
CY2009	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-528000	USD
CY2009	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	294000	USD
CY2009	exas	Warrant Licensing Expense WarrantLicensingExpense	1779000	USD
CY2009	us-gaap	Deferred Revenue Revenue Recognized DeferredRevenueRevenueRecognized	-4733000	USD
CY2009	us-gaap	Share Based Compensation ShareBasedCompensation	2631000	USD
CY2009	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	95000	USD
CY2009	us-gaap	Depreciation Depreciation	80000	USD
CY2010	us-gaap	Deferred Compensation Arrangement With Individual Employer Contribution DeferredCompensationArrangementWithIndividualEmployerContribution	65000	USD
CY2010	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss	-2000	USD
CY2010	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	85189000	USD
CY2010	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	500000	USD
CY2010	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	466000	USD
CY2010	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	82327000	USD
CY2010	us-gaap	Proceeds From Collaborators ProceedsFromCollaborators	1896000	USD
CY2010	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-14883000	USD
CY2010	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	626000	USD
CY2010	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	10241000	USD
CY2010	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	24498000	USD
CY2010	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-13478000	USD
CY2010	us-gaap	Increase Decrease In Royalties Payable IncreaseDecreaseInRoyaltiesPayable	-988000	USD
CY2010	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	20000	USD
CY2010	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	667000	USD
CY2010	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	873000	USD
CY2010	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-238000	USD
CY2010	exas	Warrant Licensing Expense WarrantLicensingExpense	107000	USD
CY2010	us-gaap	Deferred Revenue Revenue Recognized DeferredRevenueRevenueRecognized	-5318000	USD
CY2010	us-gaap	Share Based Compensation ShareBasedCompensation	2249000	USD
CY2010	us-gaap	Depreciation Depreciation	230000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35781000	USD
CY2011Q2	dei	Entity Public Float EntityPublicFloat	446504260	USD
CY2012Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	57023845	shares
CY2011	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2011
CY2011	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2010	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	82327000	USD
CY2008Q4	us-gaap	Stockholders Equity StockholdersEquity	-2433000	USD
CY2010	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	65000	USD
CY2010	exas	Compensation Expense Related To Issuance Of Stock Options And Restricted Stock Awards Values CompensationExpenseRelatedToIssuanceOfStockOptionsAndRestrictedStockAwardsValues	-2249000	USD
CY2009Q4	us-gaap	Stockholders Equity StockholdersEquity	6094000	USD
CY2011	dei	Entity Registrant Name EntityRegistrantName	EXACT SCIENCES CORP
CY2011	dei	Entity Central Index Key EntityCentralIndexKey	0001124140
CY2011	dei	Document Type DocumentType	10-K
CY2011	dei	Document Period End Date DocumentPeriodEndDate	2011-12-31
CY2011	dei	Amendment Flag AmendmentFlag	false
CY2011	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2011	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2011	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2011	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2011	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2010	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2000	USD
CY2009	exas	Stock Issued During Period Value Issues StockIssuedDuringPeriodValueIssues	4470000	USD
CY2011	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	27215000	USD
CY2009	exas	Stock Issued During Period Value In Private Placement StockIssuedDuringPeriodValueInPrivatePlacement	8062000	USD
CY2010	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	5600000	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	1500000	USD
CY2009	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	32000	USD
CY2009	exas	Compensation Expense Related To Issuance Of Stock Options And Restricted Stock Awards Values CompensationExpenseRelatedToIssuanceOfStockOptionsAndRestrictedStockAwardsValues	-1426000	USD
CY2009	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1155000	USD
CY2009	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1000	USD

Files In Submission

Name	View Source	Status
0001047469-12-002372-index-headers.html	Edgar Link	pending
0001047469-12-002372-index.html	Edgar Link	pending
0001047469-12-002372.txt	Edgar Link	pending
0001047469-12-002372-xbrl.zip	Edgar Link	pending
a2207647z10-k.htm	Edgar Link	pending
a2207647zex-23_1.htm	Edgar Link	pending
a2207647zex-31_1.htm	Edgar Link	pending
a2207647zex-31_2.htm	Edgar Link	pending
a2207647zex-32.htm	Edgar Link	pending
exas-20111231.xml	Edgar Link	completed
exas-20111231.xsd	Edgar Link	pending
exas-20111231_cal.xml	Edgar Link	unprocessable
exas-20111231_def.xml	Edgar Link	unprocessable
exas-20111231_lab.xml	Edgar Link	unprocessable
exas-20111231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EXAS
EXACT SCIENCES CORP Stock $exas

2012 Q1 Form 10-K Financial Statement

#000104746912002372 Filed on March 09, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS EXACT SCIENCES CORP Stock $exas

2012 Q1 Form 10-K Financial Statement

#000104746912002372 Filed on March 09, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS
EXACT SCIENCES CORP Stock $exas